Skip to content

School Centered Telemedicine Program for Children With Type 1 Diabetes Mellitus

School Centered Telemedicine Program for Children With Type 1 Diabetes Mellitus

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00566475
Enrollment
41
Registered
2007-12-03
Start date
2007-01-31
Completion date
2008-01-31
Last updated
2021-10-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 1 Diabetes

Brief summary

The purpose of this study is to determine if using school-based telemedicine for diabetes support and education in students with type 1 diabetes in grades K-8 can lead to improvement in control of diabetes and improved satisfaction of all caregivers.

Detailed description

Subjects, ages 5 to 14 years (grades kindergarten through eighth) were randomized to usual care (18 students; 13 schools) or intervention (23 students; 12 schools). Usual care included medical visits every 3 months and communication between school nurse and diabetes team as needed by phone. The intervention group received usual care plus a telemedicine unit in the school nurse office to videoconference between the school nurse, child, and diabetes team every month. Hemoglobin A1c and pediatric quality of life were measured every 3 months for 1 year. Analyses used multilevel modeling.

Interventions

OTHERtelemedicine

School telemedicine intervention involving school personnel, the child with type 1 diabetes and at least 1 parent

Sponsors

Department of Health and Human Services
CollaboratorFED
New York State Department of Health
CollaboratorOTHER_GOV
Children's Miracle Network
CollaboratorOTHER
State University of New York - Upstate Medical University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
5 Years to 14 Years
Healthy volunteers
No

Inclusion criteria

* Type 1 diabetes under care of Joslin Diabetes Center in Syracuse NY * Grade K-8 * Age 5-14 at time of enrollment * Consent of student, parent and school

Design outcomes

Primary

MeasureTime frame
hemoglobin A1c1 year

Secondary

MeasureTime frame
glucose levels, hypoglycemia, quality of life, satisfaction1 year

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026